Print

Print


The June 7, 1999 issue of the New Yorker magazine has a long profile
article about Dr. Harold Varmus, CEO of the NIH.  He is  a political
appointee of Clinton, brought in by Donna Shalala. His thinking has done
much to set the course of the NIH in the direction of so called pure
research, rather than as earmarking  for specific diseases. PWP,
unfortunately live in the immediacy. A case may be made for both
approaches.  Why not a compromise, e.g., putting more money where there
is a clinical payoff in sight? Dr..Varmus is personally health
conscious, a free wheeling spirit, he rides his bike to work. Good for a
healthy body, and self concept.